A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00096837 · COMPLETED
Trial details
- NCT number
- NCT00096837
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.